Similar Items: The multifaceted roles of the transcription factor SP1 in the pathogenesis of Alzheimer's disease: From molecular regulation to therapeutic targets
- Association of SPHK1 polymorphisms with Alzheimer's disease susceptibility: Functional impact of the rs2247856 SNP on transcriptional efficiency
- Deep contrastive learning framework identifies cell‐type‐specific drug targets in Alzheimer's disease
- The Indiana University Brain Health Program to deliver amyloid‐targeted therapy to Alzheimer's disease patients
- Reduced CB1 Cannabinoid Receptor Expression in Alzheimer's Disease and Transgenic Mouse Models
- Alzheimer's disease drug development pipeline: 2026
- Atrophy signature for alpha‐synuclein copathology in Alzheimer's disease